REVIEW THE NATIONAL AND GLOBAL IMPACT OF COPD * Tina V. Hartert, MD, MPH, and Mary G. Gabb, MS ABSTRACT DEFINING COPD
|
|
- Coral Stewart
- 6 years ago
- Views:
Transcription
1 THE NATIONAL AND GLOBAL IMPACT OF COPD * Tina V. Hartert, MD, MPH, and Mary G. Gabb, MS ABSTRACT Chronic obstructive pulmonary disease (COPD) is a widespread, under-recognized, and underdiagnosed disease. Underestimates of the prevalence and attributable mortality rates are multifactorial, and include: an asymptomatic disease period, an aging worldwide population that was not previously at risk because the average life expectancy even in smokers was less than age 5, and increasing use of tobacco worldwide. COPD is the forth most common cause of death in the United States and ranges from fifth to 14th worldwide. Mortality from COPD is increasing most rapidly in those areas of the world with the greatest tobacco use, and among women. Of the 1 most common causes of death in the United States, COPD is the only disease with an increasing mortality rate. The impact of this disease on women is also evidenced by attributable mortality, which is increasing at a faster rate in women than men, and is now the fourth most common cause of death among women. COPD is largely a preventable disease. Primary prevention aimed at preventing smoking initiation and smoking cessation are the most effective and cost-efficient interventions for reducing the risk of developing COPD and stopping its progression. While smoking rates overall are declining in the United States, the fastest growing group of smokers in the United States is teenage girls. Primary prevention efforts should *Based on the course curriculum from the Johns Hopkins Lecture Series. Assistant Professor of Medicine, Vanderbilt University Center for Lung Research, Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, Tennessee. Senior Contributing Editor, Advanced Studies in Medicine, Somerville, New Jersey. Address correspondence to: Tina V. Hartert, MD, MPH, Vanderbilt University Medical Center, Division of Allergy, Pulmonary & Critical Care Medicine, Center for Health Services Research, Suite 61 MCE, Nashville, TN tina.hartert@vanderbilt.edu. target this vulnerable group who are likely to smoke as adults and during pregnancy. The economic burden of COPD is high, with annual direct and indirect costs comparable to asthma and hypertension. COPD can be both prevented and diagnosed prior to symptom onset if the appropriate risk factors are identified and spirometry is performed in at-risk patients. (Adv Stud Med. 24;4(1A):S738-S743) DEFINING COPD Until recently, chronic obstructive pulmonary disease (COPD) has been a disease virtually unknown by the general public. COPD has only very recently been called the other lung disease by the lay press. 1 Such lack of awareness is a result of imprecise definitions of the disease, lack of routine screening for this disease and thus, poor estimates of prevalence, morbidity, and mortality. The World Health Organization (WHO) along with the National Heart, Lung and Blood Institute developed a global strategy on the diagnosis, management, and prevention of COPD, termed the Global Initiative for Chronic Obstructive Lung Disease (GOLD), and has published their reports and executive summaries, which are available online ( 2 First published in 21, these guidelines are updated about every 2 years. The American Thoracic Society and the European Respiratory Society also publish expert guidelines on COPD, including specific strategies for those in primary care ( 3 According to the GOLD guidelines, COPD is defined as a disease state characterized by airflow limitation that is not fully reversible. The airflow limitation is usually both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases. 2 This definition seeks to dis- S738 Vol. 4 (1A) November 24
2 tinguish COPD from asthma. Traditionally, COPD was considered to be a mixture of emphysema, chronic bronchitis, and asthma. However, with an improved understanding of the pathophysiology of COPD, we now realize that while COPD is also an inflammatory disease, it differs from asthma in several important ways: inflammatory mediators (asthma is primarily a disease characterized by eosinophilic inflammation, and COPD is characterized primarily by neutrophilic inflammation), response to treatment, and reversibility (Figure 1). 2,4,5 While some patients have both diseases, asthma can usually be distinguished from COPD. COPD comprises 2 major diseases that often coexist emphysema and chronic bronchitis. Emphysema describes the destruction of gas-exchanging surfaces (alveolae septa) leading to airspace enlargement and loss of elasticity. 6 Chronic bronchitis is formally defined as the presence of cough or sputum production for at least 3 months in each of 2 consecutive years, however, most patients have perennial cough and phlegm. 7 The contributions of airway obstruction and destruction of lung parenchyma (ie, the gas-exchanging surfaces) to COPD development vary with each patient. 2 The key concepts, therefore, for defining COPD are progressive airflow obstruction that is not fully reversible. The extent of reversibility is important not only in distinguishing COPD from asthma, but also in the healthcare practitioner s approach to treating COPD. COPD IN THE UNITED STATES: PREVALENCE AND MORTALITY Because of the prior differences and ambiguities in the definitions for COPD, there is a paucity of reliable epidemiologic data on its prevalence. Nonetheless, recent studies provide a clearer picture on the prevalence and impact of this disease. While COPD has historically been considered to be a disease of older male smokers, a 21 survey by the National Center for Health Statistics shows that the prevalence of both chronic bronchitis and emphysema were not only widely distributed among all adult age groups, but also more frequent among women (Figures 2 and 3). 8 Men are more commonly diagnosed with emphysema, while women are more often diagnosed with chronic bronchitis. Although the annual COPD death rates have been higher in men, the death rates in women are increasing at a much faster rate than in men, and COPD is now the fourth leading cause of death in women (vs fifth in men) In fact, 2 was the first year that the total number of COPD deaths was higher in women than in men (Figure 4), and this gender difference is seen in both blacks and whites (Figure 5). 9,1 Given the roughly 2-year lag time between the Figure 1. Asthma and COPD: A Comparison of Definitions ASTHMA Sensitizing agent Asthmatic airway inflammation CD4+ T-lymphocytes Eosinophils COPD Noxious agent COPD airway inflammation CD8+ T-lymphocytes Macrophages Neutrophils Reproduced with permission. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Workshop Report, updated 23. Available at: Accessed June 14, Figure 2. Percentage of US Population with Emphysema or Chronic Bronchitis by Age (21) Percentage Reversible Airflow Limitation Emphysema Chronic bronchitis Age (years) Irreversible Data from National Center for Health Statistics, Centers for Disease Control and Prevention. Summary Health Statistics for US Adults: National Health Interview Survey, 21. Vital Health Stat. 24;1(218): Advanced Studies in Medicine S739
3 Figure 3. Percentage of US Population with Emphysema or Chronic Bronchitis by Sex and Age (21) Percentage Emphysema Chronic bronchitis initiation of smoking and resultant lung damage, the rapid rise of COPD death rates in women over the last 2 to 25 years may be related in part to advertising targeting young women smokers during these years. In 2 and 21, COPD was the fourth leading cause of death in the United States, behind heart disease, cancer, and cerebrovascular diseases (Table 1), and, like its companions in the top 4 list, it is largely preventable. 11 In fact, COPD, the major cause of which is smoking, is the number one preventable cause of death in the United States. 12 While the United States has made great strides in reducing the death rates of these other diseases, COPD remains the only major disease for which death rates are increasing, and at an alarming rate (Figure 6). 8,9,11 For primary care practitioners, COPD represents a large percentage of their patient population. COPD is at least as prevalent (24 cases per 1 person-years) as many other chronic diseases treated in primary care, such as diabetes (18.2), hypertension (5), obesity (59), and cardiovascular disease (64.4) Because COPD is frequently not recognized until the clinically advanced stages of disease, these estimates represent only the tip of the proverbial iceberg, with many millions more experiencing subclinical lung disease or who are at risk of COPD from smoking. 16 A prospective study of 153 patients admitted to a general medical service at an urban hospital showed that up to 7% to 9% of those with mild, moderate, or severe airway obstruction were not diagnosed with obstructive lung disease during their hospital stay, and only 4% were receiving a bronchodilator at hospital admission or discharge. Only those with very severe airway obstruction fared better, with 89% having the diagnosis of obstructive lung disease at discharge. 17 Thus, COPD is underrecognized both in the community and in hospital settings. Also, prevalence estimates most likely underestimate the total disease burden and Age (years) Men Women Figure 4. COPD Death Rates in Women and Men (United States, 198-2) Data from National Center for Health Statistics, Centers for Disease Control and Prevention. Summary Health Statistics for US Adults: National Health Interview Survey, 21. Vital Health Stat. 24;1(218): Males Females Figure 5.Age-Adjusted COPD Death Rates by Race and Gender (United States, ) Deaths per 1 Deaths Reproduced from Mannino et al. Chronic obstructive pulmonary disease surveillance United States, MMWR Surveill Summ. 22;51(6): US, White Male Black Male White Female Black Female Reproduced with permission. GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Executive Summary, updated 23. Available at: 1 Year S74 Vol. 4 (1A) November 24
4 attributable mortality because COPD is not only underdiagnosed, but also often cited as a contributory rather than underlying cause of death. 18 COPD, THE ECONOMIC BURDEN It is not surprising, given the enormity of its prevalence, that COPD exacts a large toll, both economically and functionally. Recent estimates show that Table 1. Rank of Death Rates for the 1 Leading Causes of Death (United States, 2-21)* 1. Heart disease 2. Cancer 3. Cerebrovascular disease 4. Chronic lower respiratory diseases 5. Accidents (unintentional injuries) 6. Diabetes mellitus 7. Influenza and pneumonia 8. Alzheimer s disease 9. Nephritis, nephrotic syndrome, and nephrosis 1. Septicemia *Rank based on number of deaths. Data from the Centers for Disease Control and Prevention. Deaths: leading causes for 21. Natl Vital Stat Rep. 23;52(9):1-86. Available at: 11 Figure 6. Percentage Change in Age-Adjusted US Death Rates from COPD and Other Major Diseases (199-2) Percentage Change HIV 48.% CAD 19.9% Stroke Cancer 6.9% 6.9% 25.5% COPD COPD = chronic obstructive pulmonary disease; CAD = coronary artery disease. Data from Mannino et al 9 ; and the US Department of Health and Human Services. 12 annual direct and indirect costs of COPD total more than $32 billion in the United States, similar to asthma and hypertension, and following diabetes and heart disease (Table 2). 14,19-21 A closer analysis of the direct costs of COPD shows that the majority of the costs are due to hospital care, but an important component of the total cost is physician services (Table 3). 19 Importantly, COPD competes for the physician s attention and resources (Figure 7), particularly with office and outpatient hospital visits. 9,22 The indirect costs for this disease are also enormous. Recent reports show that COPD is second only to heart disease in the number of patients receiving Social Security disability benefits. 23 More than 19 people younger than 65 years of age are on Social Security disability due to respiratory conditions, primarily COPD. 24 Ironically, COPD is easily diagnosed with spirometry, a technology that has become easy to use in any office-based setting. A more direct analysis shows that COPD greatly impairs functionality in daily activities. Comparing people with self-reported COPD to those without, Mannino et al showed that almost 4% of those with COPD have some activity limitation (vs 18% in those without COPD); 34% of those with COPD have difficulty walking even a quarter of a mile (vs 11%); and 3% experience difficulty in lifting or carrying 1 pounds (vs 9.5%). 9 COPD WORLDWIDE COPD currently ranks as the fifth leading cause of death in the world (ranging from fifth to 14th worldwide), behind cardiovascular and cerebrovascular dis- Table 2. Estimated Annual Cost of COPD in the United States: A Comparison of Direct and Indirect Costs with Other Major Diseases Direct ($ billion) Indirect ($ billion) Diabetes Heart disease COPD Asthma Hypertension Data from the American Heart Association 14 ; the National Heart, Lung and Blood Institute/National Institutes of Health 19 ; Hogan et al 2 ; and the American Lung Association. 21 Advanced Studies in Medicine S741
5 eases, acute lower respiratory infections, and HIV/AIDS (Table 4). 25 COPD was estimated to be responsible for 2.5 million deaths worldwide in Almost 15 years ago, COPD was ranked as the 12th leading cause of disease burden (measured by disability-adjusted life-years) worldwide. 27 By 22, it is projected to rank fifth as a burden of disease and to become the third leading cause of death in the world. 2,27 Many factors contribute to the rising prevalence of COPD, namely the growing proportion of elderly in the general population and the increasing use of tobacco in some areas of the world. 2 Worldwide, the number of persons over the age of 6 is projected to triple by 25. Those in the oldest old group (8+ years) will increase more than 5-fold. 28 The population aged 6 years or older accounts for 19% of the total population in more developed countries and 8% in less developed regions; by 25, those proportions are expected to increase to 32% and 2%, respectively. 28 Projections from the US Census Bureau indicate that the percentage of people over age 65 will nearly double in the next 5 years and that the subgroup of those over 85 years of age is growing most rapidly. 29 This latter group is expected to experience a nearly 4% increase in percentage of the US population by mid-century. 29 Currently, 1 in 8 persons in the United States is at least 65 years of age; by 22, that proportion will be 1 in Unfortunately, the fastest growing group of smokers (at least in the United States) is teenage girls, and most people who start smoking as teenagers will continue to smoke as adults. As with the US prevalence estimates, the worldwide estimates are not precise, but important trends are noted. COPD is most prevalent in countries or societies with the highest tobacco use. In the United States, 47.2 million people smoke (28% of men, 23% of women). Worldwide, the WHO estimates there are 1.1 billion smokers, with an expected increase to 1.6 billion by 225. The fasting growing rates are found in low- and middle-income countries ie, those that can least afford the toll on their healthcare system that COPD will eventually take. 1 Lastly, in underdeveloped countries, indoor air pollution (particularly the use of biomass fuels) represents another important but less commonly recognized risk factor for COPD. 2 CONCLUSION COPD is a widespread and often underrecognized and underdiagnosed disease. Underestimates of its prevalence and attributable mortality are multifactorial. Yet, 2 important trends emerge: COPD is a growing cause of morbidity and mortality in the United States and worldwide, and the rates of COPD-attributable deaths are growing most rapidly in those areas of the world with the greatest tobacco use. In the United States, while deaths related to the top 1 most common causes of death are decreasing, COPD is the only major disease with an increasing mortality rate. Prevalence of COPD is increasing at a faster rate in women than in men. Even though it is underrecog- Table 3. Breakdown of Direct Costs of COPD versus Asthma Cost ($ billion) Hospital care 7.3 Prescription drugs 3.7 Physician services 3.4 Nursing home care 2.7 Home healthcare.8 Data from Morbidity and Mortality. 22 Chart Book on Cardiovascular, Lung, and Blood Diseases. NIH/NHLBI. May Figure 7. COPD Competes for the Physician s Attention and Resources Million Physician office and hospital outpatient visits COPD Asthma Diabetes Heart disease ED visits Hospitalizations Deaths Data for disease and year of statistics: COPD, 2; asthma, diabetes, 22; heart disease, 21 and 22. Data for ED visits for diabetes and heart disease are not available. COPD = chronic obstructive pulmonary disease; ED = emergency department. Data from Mannino et al 9 ; and the Centers for Disease Control and Prevention. 22 S742 Vol. 4 (1A) November 24
6 Table 4. Leading Causes of Mortality in the World 1. Cardiovascular diseases 2. Cerebrovascular diseases 3. Acute lower respiratory infections 4. HIV/AIDS 5. COPD 6. Diarrheal diseases 7. Perinatal conditions 8. Tuberculosis 9. Cancer of trachea/bronchus/lung 1. Road traffic accidents Data from World Health Organization (WHO). World Health Report WHO; nized, COPD consumes a substantial amount of the primary care practitioner s resources. Yet, it can be diagnosed early if the appropriate risk factors are identified and spirometry is performed in at-risk patients. REFERENCES 1. Lemonick MD. The other lung disease. Time. April 19, GOLD. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Workshop Report, updated 23. Available at: Accessed June 14, American Thoracic Society. Standards for the diagnosis and management of patients with COPD. Available at: Accessed July 6, Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax. 1998;53(2): Barnes PJ. Mechanisms in COPD: differences from asthma. Chest. 2;117(suppl):1S-14S. 6. Dorland s Illustrated Medical Dictionary, 28th edition. Philadelphia, PA: WB Saunders; Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med. 2;343(4): National Center for Health Statistics, Centers for Disease Control and Prevention. Summary Health Statistics for US Adults: National Health Interview Survey, 21. Vital Health Stat. 24;1(218): Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC. Chronic obstructive pulmonary disease surveillance United States, MMWR Surveill Summ. 22; 51(6): GOLD web site. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Teaching slide set. Available at: Accessed June 14, Centers for Disease Control and Prevention. Deaths: leading causes for 21. Nat Vital Stat Rep. 23;52(9):1-86. Available at: nchs/data/nvsr/nvsr52/nvsr52_9.pdf. Accessed June 14, US Department of Health and Human Services. Health, United States, 23 with Chartbook on Trends in the Health of Americans. DHHS publication ; September 23. Available at: nchs/data/hus/hus3.pdf. Accessed June 17, American Diabetes Association web site. All about diabetes. Available at: Accessed June 14, American Heart Association. Heart Disease and Stroke Statistics 24 Update. Dallas, TX: AHA; Centers for Disease Control and Prevention web site. Frequently asked questions on overweight and obesity. Available at: obesity/faq.htm#adults. 16. Mannino DM, Gagnon RC, Petty TL, Lydick E. Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, Arch Intern Med. 2;16(11): Zaas D, Wise R, Wiener C; Longcope Spirometry Investigation Team. Airway obstruction is common but unsuspected in patients admitted to a general medicine service. Chest. 24;125(1): Mannino DM, Brown C, Giovino GA. Obstructive lung disease deaths in the United States from 1979 through An analysis using multiple-cause mortality data. Am J Respir Crit Care Med. 1997;156(3, pt 1): Morbidity and Mortality. 22 Chart Book on Cardiovascular, Lung, and Blood Diseases. NIH/NHLBI. May Hogan P, Dall T, Nikolov P, American Diabetes Association. Economic costs of diabetes in the US in 22. Diabetes Care. 23;26(3): American Lung Association web site. Available at: Accessed June 21, National Center for Health Statistics. CDC web site. Fast stats A to Z. Available at: default.html. Accessed June 14, Agency for Healthcare Research and Quality. Focus on Research. AHRQ publication 2-M16; March 22. Available at: www. ahrq.gov. Accessed May 1, Social Security Online. Available at: Accessed May 1, World Health Organization (WHO). World Health Report WHO; World Health Organization. Number of Registered Deaths. WHO Mortality Database. 25 Feb Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause : Global Burden of Disease Study. Lancet. 1997;349(964): United Nations, World Population Prospects: the 22 update. Available at: Accessed July 6, US Census Bureau web site. U.S. interim projections by age, sex, race, and Hispanic origin. Available at: gov/ipc/www/usinterimproj/. Accessed July 6, 24. Advanced Studies in Medicine S743
American Thoracic Society (ATS) Perspective
National Surveillance System for Chronic Lung Disease (CLD): American Thoracic Society (ATS) Perspective Gerard J. Criner, M.D. Chronic Obstructive Pulmonary Disease (COPD) l Definition: Group of chronic
More informationCHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE Chronic Obstructive Pulmonary Disease (COPD) is a slowly progressive disease of the airways that is characterized by a gradual loss of lung function. In the U.S.,
More informationTrends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. Please note, this report is designed for double-sided printing
Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality Please note, this report is designed for double-sided printing American Lung Association Epidemiology and Statistics Unit Research
More informationUNDERSTANDING COPD MEDIA BACKGROUNDER
UNDERSTANDING COPD MEDIA BACKGROUNDER What is COPD? Chronic Obstructive Pulmonary Disease (COPD) also called emphysema and/or chronic obstructive bronchitis* is a preventable lung disease caused by the
More informationLife-long asthma and its relationship to COPD. Stephen T Holgate School of Medicine University of Southampton
Life-long asthma and its relationship to COPD Stephen T Holgate School of Medicine University of Southampton Definitions COPD is a preventable and treatable disease with some significant extrapulmonary
More informationCOPD as a comorbidity of heart failure in elderly patients
COPD as a comorbidity of heart failure in elderly patients Professor Mitja Lainscak, MD, PhD, FESC, FHFA Departments of Cardiology and Research&Education, General Hospital Celje Faculty of Medicine, University
More informationCOPD is characterized by airflow obstruction with COPD* Epidemiology, Prevalence, Morbidity and Mortality, and Disease Heterogeneity.
COPD* Epidemiology, Prevalence, Morbidity and Mortality, and Disease Heterogeneity David M. Mannino, MD, FCCP COPD continues to cause a heavy health and economic burden both in the United States and around
More information2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters
GOLD Objectives To provide a non biased review of the current evidence for the assessment, diagnosis and treatment of patients with COPD. To highlight short term and long term treatment objectives organized
More informationPrevalence of Chronic Obstructive Pulmonary Disease and Tobacco Use in Veterans at Boise Veterans Affairs Medical Center
Prevalence of Chronic Obstructive Pulmonary Disease and Tobacco Use in Veterans at Boise Veterans Affairs Medical Center William H Thompson MD and Sophie St-Hilaire DVM PhD BACKGROUND: Although its prevalence
More informationChronic Obstructive Pulmonary Disease Surveillance --- United States,
University of Kentucky From the SelectedWorks of David M. Mannino October, 2002 Chronic Obstructive Pulmonary Disease Surveillance --- United States, 1971--2000 David M. Mannino David M. Homa Lara J. Akinbami
More informationTennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center
Tennessee Department of Health in collaboration with Tennessee State University and University of Tennessee Health Science Center 2006 Tennessee Department of Health 2006 ACKNOWLEDGEMENTS CONTRIBUTING
More informationTexas Chronic Disease Burden Report. April Publication #E
Texas Chronic Disease Burden Report April 2010 Publication #E81-11194 Direction and Support Lauri Kalanges, MD, MPH Medical Director Health Promotion and Chronic Disease Prevention Section, Texas Department
More informationEpidemiology of COPD Prof. David M. Mannino, M.D.
Epidemiology of COPD David M. Mannino, M.D. Professor Department of Preventive Medicine and Environmental Health College of Public Health University of Kentucky 1 Outline Definitions Severity Progression
More informationTrends in Pneumonia and Influenza Morbidity and Mortality
Trends in Pneumonia and Influenza Morbidity and Mortality American Lung Association Epidemiology and Statistics Unit Research and Health Education Division November 2015 Page intentionally left blank Introduction
More informationDefining COPD. Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist
Defining COPD Georgina Grantham Community Respiratory Team Leader/ Respiratory Nurse Specialist Defining COPD Chronic Obstructive Pulmonary Disease (COPD) is a common, preventable and treatable disease
More informationRESPIRATORY DISORDERS
RESPIRATORY DISORDERS INTRODUCTION Respiratory disorders refers to the medical term that include different pathological conditions affecting the organs and tissues of respiratory system which make gas
More informationA Closer Look at Leading Causes of Death in Guilford County
2015 GCDHHS Division of Public Health Data Brief A Closer Look at Leading Causes of Death in Guilford County Highlights Heart disease mortality rates declined 43% from 244.8 deaths per 100,000 in 1995
More informationSurvey on Chronic Respiratory Diseases at the PrimaryHealth Care Level
Survey on Chronic Respiratory Diseases at the PrimaryHealth Care Level Nikolai Khaltaev MD, PhD GARD General Meeting Istanbul, Turkey, 30-31 May 2008 Burden of major respiratory diseases Respiratory diseases
More informationCOPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013
COPD, Asthma, Or Something In Between? Sharon R. Rosenberg Assistant Professor of Medicine Northwestern University December 4, 2013 None Disclosures Definitions Asthma Asthma is a chronic inflammatory
More informationCommissioning for Better Outcomes in COPD
Commissioning for Better Outcomes in COPD Dr Matt Kearney Primary Care & Public Health Advisor Respiratory Programme, Department of Health General Practitioner, Runcorn November 2011 What are the Commissioning
More informationKey Facts About. ASTHMA
Key Facts About. ASTHMA Asthma is a serious lung disease that can be frightening and disabling. The public is becoming increasingly aware that more people, especially children, are suffering and dying
More informationMarc Moss, MD President, American Thoracic Society (202) th St, N.W. #300 Washington, DC 20036
Marc Moss, MD President, American Thoracic Society Nmoore@thoracic.org; (202) 296. 9770 1150 18 th St, N.W. #300 Washington, DC 20036 STATEMENT OF THE AMERICAN THORACIC SOCIETY SUBMITTED TO THE HOUSE LABOR,
More informationMyths, Heart Disease and the Latino Population. Maria T. Vivaldi MD MGH Women s Heart Health Program. Hispanics constitute 16.3 % of US population!
Myths, Heart Disease and the Latino Population Maria T. Vivaldi MD MGH Women s Heart Health Program Hispanics constitute 16.3 % of US population! 1 LEADING CAUSES OF DEATH IN LATINOS Heart disease is the
More informationFighting for Air, In Emphysema
Fighting for Air, The Mechanism of Shortness of Breath In Emphysema Albert A. Rizzo, MD FCCP FACP Speaker, Nationwide Assembly of the American Lung Association & Section Chief Pulmonary/Critical Care Medicine
More information2010 YEAR OF THE LUNG: GOALS AND OBJECTIVES. J. Randall Curtis, MD, MPH Immediate Past President, ATS
2010 YEAR OF THE LUNG: GOALS AND OBJECTIVES J. Randall Curtis, MD, MPH Immediate Past President, ATS 2010 Year of the Lung What is Year of the Lung? Whey do we need a Year of the Lung? What does Year of
More informationAsthma and Chronic Obstructive Pulmonary Disease
Asthma and Chronic Obstructive Pulmonary Disease Variables Adults have asthma Students who have asthma Asthma hospitalizations COPD hospitalizations What is it? Asthma and chronic obstructive pulmonary
More informationChronic respiratory disease: towards better treatments
Chronic respiratory disease: towards better treatments Alaina J. Ammit PhD Alaina.Ammit@uts.edu.au Professor of Respiratory Pharmacology, UTS Director, Woolcock Emphysema Centre, Woolcock Institute of
More informationCOPD and environmental risk factors other than smoking. 14. Summary
COPD and environmental risk factors other than smoking 14. Summary Author : P N Lee Date : 7 th March 2008 1. Objectives and general approach The objective was to obtain a good insight from the available
More informationThe development of chronic obstructive pulmonary
THE PATHOGENESIS AND PATHOLOGY OF COPD: IDENTIFYING RISK FACTORS AND IMPROVING MORBIDITY AND MORTALITY * Paul D. Scanlon, MD ABSTRACT Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory
More informationDifferential diagnosis
Differential diagnosis The onset of COPD is insidious. Pathological changes may begin years before symptoms appear. The major differential diagnosis is asthma, and in some cases, a clear distinction between
More informationCOPD: Current Medical Therapy
COPD: Current Medical Therapy Angela Golden, DNP, FNP-C, FAANP Owner, NP from Home, LLC Outcomes As a result of this activity, learners will be able to: 1. List the appropriate classes of medications for
More informationChronic Obstructive Pulmonary Disease (COPD) Clinical Guideline
Chronic Obstructive Pulmonary Disease (COPD) Clinical These clinical guidelines are designed to assist clinicians by providing an analytical framework for the evaluation and treatment of patients. They
More informationPage 126. Type of Publication: Original Research Paper. Corresponding Author: Dr. Rajesh V., Volume 3 Issue - 4, Page No
ISSN- O: 2458-868X, ISSN P: 2458 8687 Index Copernicus Value: 49. 23 PubMed - National Library of Medicine - ID: 101731606 SJIF Impact Factor: 4.956 International Journal of Medical Science and Innovative
More informationImproving Outcomes in COPD
Neil MacIntyre MD Duke University Durham NC Current treatment guidelines f COPD focus Barriers to providing optimal treatment Diagnosis of COPD EXPOSURE TO RISK FACTORS AND/ OR SYMPTOMS sputum cough dyspnea
More informationLooking Toward State Health Assessment.
CONNECTICUT DEPARTMENT OF PUBLIC HEALTH Policy, Planning and Analysis. Looking Toward 2000 - State Health Assessment. Table of Contents Glossary Maps Appendices Publications Public Health Code PP&A Main
More informationBecause we care about your health
Contact us For information on Trust services see www.awp.nhs.uk PALS To make a comment, raise a concern or make a complaint, please contact the Trust s Patient Advice and Liaison Service (PALS). Smoking
More informationTACKLING COPD READMISSIONS. Wendy Presley RN
TACKLING COPD READMISSIONS Wendy Presley RN WHY START WITH COPD? HIGH VOLUME PROBLEM PRONE COSTLY And you just can t resist a challenge Chronic Obstructive Pulmonary Disease (COPD) is a preventable and
More informationWorcester County Report Card 2012
Worcester County Report Card 2012 W H Deborah Goeller, R.N., M.S. Health Officer Introduction This community health 2012 Report Card is the fourth published by the Worcester County Health Department. There
More informationReduce Costs, Prevent Disease, Improve Employee Health
Reduce Costs, Prevent Disease, Improve Employee Health Using Proven Policies and Programs for Effective Change Texas Department of State Health Services Cardiovascular Health and Wellness Program From
More informationThe Direct Medical Costs of Undiagnosed Chronic Obstructive Pulmonary Disease
Volume 11 Number 4 2008 VALUE IN HEALTH The Direct Medical Costs of Undiagnosed Chronic Obstructive Pulmonary Disease Douglas W. Mapel, MD, 1 Scott B. Robinson, MPH, 1 Homa B. Dastani, PhD, 2 Hemal Shah,
More informationyrs life expectancy for women in 1900
Come Join Us to Help Celebrate Women s Health! The Office of Women s Health (OWH) serves to educate the public and to be an advocate for women s health. The goal of this calendar is to present the 10 leading
More informationChronic Obstructive Pulmonary Disease
Page 1 of 5 Chronic Obstructive Pulmonary Disease Chronic Obstructive Pulmonary Disease (COPD) is an 'umbrella' term for people with chronic bronchitis, emphysema, or both. With COPD the airflow to the
More information9/22/2015 CONFLICT OF INTEREST OBJECTIVES. Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationUnderstanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR
Understanding COPD - Recent Research and the Evolving Definition of COPD for MNACVPR by Scott Cerreta, BS, RRT Director of Education www.copdfoundation.org scerreta@copdfoundation.org CONFLICT OF INTEREST
More informationPeople with asthma who smoke. The combination of asthma, a chronic airway disease, and smoking increases the risk of COPD even more.
COPD Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, sputum (phlegm) production
More informationProvider Respiratory Inservice
Provider Respiratory Inservice 2 Welcome Opening Remarks We will cover: Definition of Asthma & COPD Evidence based guidelines for diagnosis, evaluation, and management of asthma Evidence based guidelines
More informationCardiovascular Disease in Tennessee. Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health
Cardiovascular Disease in Tennessee Audrey M Bauer, DVM, MPH Surveillance, Epidemiology and Evaluation Tennessee Department of Health Practical Strategies in Medication Adherence for Cardiac and Stroke
More informationASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?
ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss? Randall W. Brown, MD MPH AE-C Association of Asthma Educators Annual Conference July 20, 2018 Phoenix, Arizona FACULTY/DISCLOSURES Randall Brown,
More informationThe State of Asthma in Arkansas
2013 The State of Asthma in Arkansas Jennifer Maulden, MA Martha Phillips, PhD University of Arkansas for Medical Sciences Fay W. Boozman College of Public Health This project was supported by Award Number
More informationThe Burden of Cardiovascular Disease in North Carolina June 2009 Update
The Burden of Cardiovascular Disease in North Carolina June 2009 Update Sara L. Huston, Ph.D. Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section Division of Public Health North Carolina
More informationHealtheCNY Indicator List by Data Source
American Community Survey 23 Adults with Health Insurance Children Living Below Poverty Level Children with Health Insurance Families Living Below Poverty Level Homeowner Vacancy Rate Homeownership Households
More informationHow to treat COPD? What is the mechanism of dyspnea? Smoking cessation
: The Increasing Role of the FP Alan Kaplan, MD, CCFP(EM) Presented at the Primary Care Today: Education Conference and Medical Exposition, Toronto, Ontario, May 2006. Chronic obstructive pulmonary disease
More informationFigure 1: COPD Age Adjusted Death Rates Based on the 1940 and 2000 Standard Population,
Figure 1: COPD Age Adjusted Death Rates Based on the 1940 and 00 Standard Population, 1979-00 Age Adjusted Death Rates per 100,000 Persons 50 45 40 35 30 25 15 10 Years 1979 1980 1981 1982 1983 1984 1985
More informationJUSTUS WARREN TASK FORCE MEETING DECEMBER 05, 2012
SAMUEL TCHWENKO, MD, MPH Epidemiologist, Heart Disease & Stroke Prevention Branch Chronic Disease & Injury Section; Division of Public Health NC Department of Health & Human Services JUSTUS WARREN TASK
More informationTHE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable
THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable This activity is supported by an educational grant from Sunovion Pharmaceuticals Inc. COPD in the United States Third leading cause
More informationThis is a cross-sectional analysis of the National Health and Nutrition Examination
SUPPLEMENTAL METHODS Study Design and Setting This is a cross-sectional analysis of the National Health and Nutrition Examination Survey (NHANES) data 2007-2008, 2009-2010, and 2011-2012. The NHANES is
More informationAdvances in the management of chronic obstructive lung diseases (COPD) David CL Lam Department of Medicine University of Hong Kong October, 2015
Advances in the management of chronic obstructive lung diseases (COPD) David CL Lam Department of Medicine University of Hong Kong October, 2015 Chronic obstructive pulmonary disease (COPD) COPD in Hong
More information2017 State Of The County Health Report Jones County, NC
217 State Of The County Health Report Jones County, NC Promoting sound health policies, preventing and controlling the spread of disease, and safeguarding the integrity of the environment for all citizens
More informationCOPD COPD. C - Chronic O - Obstructive P - Pulmonary D - Disease OBJECTIVES
COPD C - Chronic O - Obstructive P - Pulmonary D - Disease 1 OBJECTIVES Following this presentation the participant should be able to demonstrate understanding of chronic lung disease by successful completion
More informationLeading Causes of Death in US (2013-CDC):
Leading Causes of Death in 1. Heart disease: 611,105 US (2013-CDC): 2. Cancer: 584,881 3. Chronic lower respiratory diseases (Emphysema and Chronic Bronchitis): 149,205 4. Accidents (unintentional injuries):
More informationLecture Notes. Chapter 4: Chronic Obstructive Pulmonary Disease (COPD)
Lecture Notes Chapter 4: Chronic Obstructive Pulmonary Disease (COPD) Objectives Define COPD Estimate incidence of COPD in the US Define factors associated with onset of COPD Describe the clinical features
More informationCOPD. Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS
IN THE NAME OF GOD COPD Dr.O.Paknejad Pulmonologist Shariati Hospital TUMS Definition of COPD* COPD is a preventable and treatable chronic lung disease characterized by airflow limitation that is not fully
More informationCOPD Management in LTC: Presented By: Jessica Denney RRT
COPD Management in LTC: Presented By: Jessica Denney RRT Sponsored by Z & D Medical Services, Diamond Sponsor Seizing Opportunities to Provide Individualized Treatment and Device Selection for your COPD
More informationChronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease 07 Contributor Dr David Tan Hsien Yung Definition, Diagnosis and Risk Factors for (COPD) Differential Diagnoses Goals of Management Management of COPD THERAPY AT EACH
More informationPrince Edward Island Chronic Obstructive Pulmonary Disease (COPD) Trends
Prince Edward Island Chronic Obstructive Pulmonary Disease (COPD) Trends 2001-2011 December 2014 Population Health Assessment and Surveillance Unit, Chief Public Health Office, Department of Health and
More informationSpeaker Disclosure. Identification and Diagnosis of Asthma. Definition of Asthma. Objectives 11/9/2017
Speaker Disclosure Identification and Diagnosis of Asthma Isabel L. Virella Lowell, MD, Associate Professor, Pulmonology and Sleep Medicine, University of Alabama at Birmingham Isabel Virella-Lowell, MD
More informationThe role of blood eosinophil level in acute exacerbation of Chronic Obstructive Pulmonary Disease
112 Original Article The role of blood eosinophil level in acute exacerbation of Chronic Obstructive Pulmonary Disease Department of Pulmonology and Critical Care Medicine, Tribhuvan University Teaching
More informationAround-COPD Verona (Italy), January Highlights
Introduction Around-COPD Verona (Italy), January 18 2017 Highlights Prof. Dal Negro chairman of the symposium, opened the congress by highlighting the burden of COPD as a chronic invalidating disease affecting
More informationAsthma COPD Overlap (ACO)
Asthma COPD Overlap (ACO) Dr Thomas Brown Consultant Respiratory Physician Thomas.Brown@porthosp.nhs.uk Dr Hitasha Rupani Consultant Respiratory Physician Hitasha.rupani@porthosp.nhs.uk What is Asthma
More informationCOPD: A Renewed Focus. Disclosures
COPD: A Renewed Focus Heath Latham, MD Assistant Professor Division of Pulmonary and Critical Care Medicine Disclosures No Business Interests No Consulting No Speakers Bureau No Off Label Use to Discuss
More informationCOPD UPDATE ıdr Shitrit David ıhead of the Pulmonary Department ımeir Medical Center
COPD UPDATE 2012 ıdr Shitrit David ıhead of the Pulmonary Department ımeir Medical Center Definition of COPD COPD is a preventable and treatable disease with some significant extra pulmonary effects that
More informationRespiratory diseases in Ostrołęka County
Respiratory diseases in Ostrołęka County 4400 persons underwent examination 950 persons were given referrals to more detailed investigation 600 persons were examined so far The results of more detailed
More informationSymptomatology and Health Status in Patients With Chronic Obstructive Pulmonary Disease
ORIGINAL ARTICLE Symptomatology and Health Status in Patients With i&&tjljl!11b hi 2 L C Loh, MRCP, C H Lai,O H Liew, Y Y Siow IMU Lung Research, International Medical University, Clinical School, Jalan
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
DRAFT NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary
More informationLiving well with COPD
This factsheet aims to show people with chronic obstructive pulmonary disease (COPD) and their friends and family how they can live a full life with this disease. What is COPD? COPD is a condition that
More informationCommunity Health Needs Assessment for UI Health Hospital & Clinics
Community Health Needs Assessment for UI Health Hospital & Clinics Office of the Vice Chancellor for Health Affairs Community Engagement & Neighborhood Health Health Policy & Strategy Population Health
More informationan inflammation of the bronchial tubes
BRONCHITIS DEFINITION Bronchitis is an inflammation of the bronchial tubes (or bronchi), which are the air passages that extend from the trachea into the small airways and alveoli. Triggers may be infectious
More informationChronic Obstructive Pulmonary Disease (COPD).
Chronic Obstructive Pulmonary Disease (COPD). Linde: Living healthcare 02 03 Chronic Obstructive Pulmonary Disease (COPD). A pocket guide for healthcare professionals. COPD the facts Moderate to severe
More informationCHRONIC OBSTRUCTIVE PULMONARY DISEASE
CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEFINITION Chronic obstructive pulmonary disease (COPD) is a common preventable and treatable disease characterized by airflow limitation that is usually progressive
More informationHealthStats HIDI JUNE 2014 MEN S HEALTH MONTH
HIDI HealthStats Statistics and Analysis From the Hospital Industry Data Institute According to the Centers for Disease Control and Prevention, the top four causes of death in the United States are heart
More informationBeyond the Next Breath: Controlling Costs and Maximizing COPD Outcomes
Beyond the Next Breath: Controlling Costs and Maximizing COPD Outcomes Edith Haage, PT, GCS NewCourtland Senior Services 10/21/2015 NEWCOURTLAND.org 1-888-530-4913 http://www.poliosurvivorsnetwork.org.uk/archive/lincolnshire/library/australia/paleop/ima
More informationBaseline Health Data Report: Cambria and Somerset Counties, Pennsylvania
Baseline Health Data Report: Cambria and Somerset Counties, Pennsylvania 2017 2018 Page 1 Table of Contents Executive Summary.4 Demographic and Economic Characteristics 6 Race and Ethnicity (US Census,
More informationCigarette Smoking and Lung Obstruction Among Adults Aged 40 79: United States,
NCHS Data Brief No. 8 January 25 Cigarette Smoking and Lung Obstruction Among Adults Aged 4 79: United States, 27 22 Ryne Paulose-Ram, Ph.D., M.A.; Timothy Tilert, B.S.; Charles F. Dillon, M.D., Ph.D.;
More informationUniversity Journal of Pre and Paraclinical Specialities
University Journal of Pre and Paraclinical Specialities Volume 1 Issue 1 2015 A COMPARISON OF COGNITIVE FUNCTIONS IN STABLE PATIENTS WITH COPD AND AGE-MATCHED HEALTHY VOLUNTEERS USING MINI-MENTAL STATE
More informationCOPD Awareness & Education
COPD Awareness & Education Women In Government Foundation, Inc. Women In Government Foundation, Inc. is a national, non-profit, non-partisan organization of women state legislators providing leadership
More informationOutline FEF Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications?
Reduced FEF25-75 in asthma. What does it mean and what are the clinical implications? Fernando Holguin MD MPH Director, Asthma Clinical & Research Program Center for lungs and Breathing University of Colorado
More informationFort Ha milton Hospital. Community Benefit Plan & Implementation Strategy
201 4 Fort Ha milton Hospital Community Benefit Plan & Implementation Strategy TABLE OF CONTENTS INTRODUCTION... 2 Fort Hamilton Hospital Service Area... 2 Community Health Needs Assessment... 2 Data Collection...
More informationThe Aging Lung. Sidney S. Braman MD FACP FCCP Professor of Medicine Brown University Providence RI
The Aging Lung Sidney S. Braman MD FACP FCCP Professor of Medicine Brown University Providence RI Is the respiratory system of the elderly different when compared to younger age groups? Respiratory Changes
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Chronic obstructive pulmonary disease: the management of adults with chronic obstructive pulmonary disease in primary and secondary
More informationGlobal Burden of Respiratory Disease Lessons from Afar Scott Barnhart, MD, MPH June 18, 2010
Global Burden of Respiratory Disease Lessons from Afar Scott Barnhart, MD, MPH June 18, 2010 Scott Barnhart, MD, MPH June 18, 2010 Three Goals An Overview of the global burden of respiratory disease relative
More informationWhat s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university
What s new in COPD? Apichart Khanichap MD. Department of Medicine, Faculty of Medicine, Thammasat university Management stable COPD Relieve symptoms Improve exercise tolerance Improve health status Prevent
More informationC hronic obstructive pulmonary disease (COPD) is one of
935 CHRONIC OBSTRUCTIVE PULMONARY DISEASE Developing COPD: a 25 year follow up study of the general population A Løkke, P Lange, H Scharling, P Fabricius, J Vestbo... See end of article for authors affiliations...
More informationAECOPD: Management and Prevention
Neil MacIntyre MD Duke University Medical Center Durham NC Professor P.J. Barnes, MD, National Heart and Lung Institute, London UK Professor Peter J. Barnes, MD National Heart and Lung Institute, London
More informationConference Report. Chronic Obstructive Pulmonary Disease From a Payer and Provider Lens. Managed Care & Healthcare Communications, LLC
AUTHOR Joseph Johnson, MD Chief Medical Officer Arizona Integrated Physicians PUBLISHING STAFF Senior Vice President, Clinical and Scientific Affairs Jeff Prescott, PharmD, RPh Clinical Projects Managers
More informationThe Burden of Cardiovascular Disease in Illinois. Mortality, Morbidity and Risk Factors 2013
The Burden of Cardiovascular Disease in Illinois Mortality, Morbidity and Risk Factors 2013 Table of Contents Executive Summary... iii Introduction... 1 Cardiovascular Disease Mortality... 2 Heart Disease
More informationAchieving Quality and Value in Chronic Care Management
The Burden of Chronic Disease One of the greatest burdens on the US healthcare system is the rapidly growing rate of chronic disease. These statistics illustrate the scope of the problem: Nearly half of
More informationThe Burden of Cardiovascular Disease in North Carolina. Justus-Warren Heart Disease and Stroke Prevention Task Force April 11, 2018
The Burden of Cardiovascular Disease in North Carolina Justus-Warren Heart Disease and Stroke Prevention Task Force April 11, 2018 Purpose 1. To detail the burden of heart disease and stroke in North Carolina
More informationChronic Obstructive Pulmonary Disease (COPD) Measures Document
Chronic Obstructive Pulmonary Disease (COPD) Measures Document COPD Version: 3 - covering patients discharged between 01/10/2017 and present. Programme Lead: Jo Higgins Clinical Lead: Dr Paul Albert Number
More informationUniversity Journal of Pre and Para Clinical Sciences
ISSN 2455 2879 Volume 2 Issue 2 2016 A COMPARISON OF COGNITIVE FUNCTIONS IN STABLE PATIENTS WITH COPD AND AGE-MATCHED HEALTHY VOLUNTEERS USING MINI-MENTAL STATE EX- AMINATION QUESTIONNAIRE. PALANI S SUBRAMANIAM
More information